Skip to main content
Venus Medtech (Hangzhou) Inc. logo

Venus Medtech (Hangzhou) Inc. — Investor Relations & Filings

Ticker · 2500 ISIN · CNE100003PJ8 HKEX Manufacturing
Open in API
Filings indexed 359 across all filing types
Latest filing 2026-05-19 Legal Proceedings Report
Country HK Hong Kong
Listing HKEX 2500

About Venus Medtech (Hangzhou) Inc.

http://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc. is an innovation-driven medical device company specializing in the research, development, manufacturing, and commercialization of transcatheter solutions for structural heart diseases. The company focuses on bioprosthetic heart valves, establishing a comprehensive pipeline that addresses aortic, pulmonary, mitral, and tricuspid valve diseases. Its product portfolio includes transcatheter aortic valve replacement (TAVR) solutions, and it is committed to addressing unmet demand in TPVR and TMVR. The company also develops solutions for hypertension, such as renal artery denervation ablation, and related surgical accessory products. Its products are commercialized globally, reaching over 60 countries and regions across Asia, Europe, and the Americas.

Recent filings

Filing Released Lang Actions
Exchange's Disciplinary Action against Former Company Secretary of Venus Medtech (Hangzhou) Inc. (Stock Code: 2500)
Legal Proceedings Report Classification · 95% confidence The document is a detailed statement from the Stock Exchange of Hong Kong Limited regarding disciplinary action against a former company secretary of a listed company. It discusses breaches of listing rules, governance failures, and sanctions imposed on the individual. The content focuses on regulatory compliance, governance issues, and disciplinary measures rather than financial results, earnings, or capital changes. It is not an annual report, earnings release, or management report. It is also not a simple announcement or certification but a formal disciplinary report issued by a regulatory body. Therefore, the document fits best under the category of Legal Proceedings Report (LTR), as it details regulatory actions and sanctions related to governance and compliance breaches.
2026-05-19 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 90% confidence The document is a formal announcement from Venus Medtech listing the company’s board of directors and their committee roles. It does not contain financial data, shareholder voting results, or refer to an attached report. It announces board composition and management roles, fitting the criteria for Board/Management Information.
2026-05-15 English
RESIGNATION OF A DIRECTOR
Board/Management Information Classification · 93% confidence The document is a Hong Kong Exchange announcement regarding the resignation of an executive director, detailing board composition changes and director’s personal commitments. It is clearly a board/management change notice rather than a financial report or other regulatory filing.
2026-05-15 English
CHANGE OF COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVES
Board/Management Information Classification · 100% confidence The document is an announcement from the board of directors of Venus Medtech (Hangzhou) Inc. regarding the resignation of the company secretary and authorized representatives and the appointment of a new company secretary and authorized representatives. It includes biographical details of the new appointee and expresses gratitude to the outgoing secretary. There is no financial data, no mention of financial results, no regulatory filings of financial nature, no voting results, no legal proceedings, no capital changes, and no report publication. The content is clearly about changes in senior management positions, specifically the company secretary and authorized representatives. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short (2878 characters), and it is not a report or announcement of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2026-05-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return filing for an equity issuer listed on the Hong Kong Stock Exchange, specifically under Chapter 19B of the Exchange Listing Rules. It contains detailed information about movements in authorized/registered share capital, issued shares, treasury shares, share options, and confirmations related to compliance with listing rules. The document is a regulatory submission reporting share capital and shareholding movements for the month ended 30 April 2026. It is not an annual or interim financial report, earnings release, or management discussion. It is also not a proxy statement, AGM material, or legal proceeding. The content aligns with a regulatory filing reporting share capital and shareholding information as required by the exchange rules. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2026-05-06 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information Classification · 100% confidence The document is titled '2025 Environmental, Social and Governance Report' and contains detailed information about the company's ESG performance, management structure, stakeholder engagement, materiality analysis, and compliance with ESG reporting standards. It explicitly states it is an ESG report covering the year 2025, prepared according to the Environmental, Social and Governance Reporting Code of the Hong Kong Stock Exchange. The content focuses on environmental, social, and governance factors rather than financial results or corporate governance rules alone. It is not an announcement or a brief summary but a full report on ESG matters. Therefore, the document fits the category of Environmental & Social Information (ESG) report.
2026-04-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.